(Report) 2nd Series on EOL (End of life) Care discussion
date : 10/23/2013
Dr. Akiyama elaborated a contextual example of how to design a life for extended life span and how to make a decision for end of life. Dr. Itoh on the other hand, opened “Hana-no-tani Clinic” near the shore of South Bōsō, Chiba prefecture in order to provide medical care that free from the boundaries of out-patient, home care, or hospice. She talked about why clinic like “Hana-no-tani” was needed and how to provide not only medical care but also to deliver life support.
———-
■Date: Oct 8 (Tuesday) 19:00-21:00
■Place: Marunouchi Building Hall&Conference Square (8F MarunouchiBuilding, 2-4-1 Marunouchi, Chiyoda-ku, Tokyo)
■Organized by: Health and Global Policy Institution, NPO
■Points of view: It allows multispectral speakers to exchange their opinions.
■Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (70 invitees)
■Participation fee:1,500Yen
Language: Japanese (No interpretation)
———-
Program
1. The 1st Review of EOL Seminar
2. Life Design and EOL Care of Hyper Aging Society
Speaker:
-Dr. Hiroko Akiyama(Project Proffessor, Executive associate member, Institute of Gerontology, the University of Tokyo)
-Dr. Mami Ito (Director of “Hana-no-tani”Clinic)
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 (Syllabary order, Titles omitted)
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/Surgeon
Exhibition date:2013-10-08
Top Research & Recommendations Posts
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Announcement] HGPI Planetary Health Policy Team Joins Call for Global Fossil Fuel Non-proliferation Treaty (October 18, 2022)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-03-04
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Issues Surrounding and Necessary Measures Against Obesity Disease” (February 2, 2024)
-
2024-03-05
[HGPI Policy Column] (No.41) – From the Mental Health Project Team – Mental Health Policy in Japan – History and Future Policy Topics (Part 1 of HGPI Activities for Mental Health and Domestic Policy History)
-
2024-03-18
[Registration Open] International Symposium “Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (April 9, 2024)
-
2024-03-22
[Registration Open] (Hybrid Format) The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Global Expert Meeting: Toward Equitable Patient Access to Genomic Cancer Medicine (April 4, 2024)
-
2024-03-26
[Policy Recommendations] Dementia Prevention Initiatives for Achieving a Dementia-Friendly and Inclusive Society (March 26, 2024)